Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

DANISH BIOFUEL A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   7.1% 7.1% 7.1% 7.1% 7.1% 7.1% 7.1% 7.1%   Bankruptcy risk   2.2% 2.7% 2.6% 3.1% 1.1% 1.1% 9.4% 9.4%   Credit score (0-100)   68 61 61 55 83 83 26 26   Credit rating   BBB BBB BBB BBB A A BB BB   Credit limit (kDKK)   6.2 0.1 0.2 0.0 4,428.8 6,123.3 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   4.9 -148 -35.2 -76.5 456 2,411 0.0 0.0   EBITDA   4.9 -148 -35.2 -76.5 456 2,411 0.0 0.0   EBIT   4.9 -148 -35.2 -76.5 456 2,411 0.0 0.0   Pre-tax profit (PTP)   46.3 -103.6 5.1 -35.2 501.3 2,577.0 0.0 0.0   Net earnings   36.1 -80.8 4.0 -35.2 398.8 2,010.0 0.0 0.0   Pre-tax profit without non-rec. items   46.3 -104 5.1 -35.2 501 2,577 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   140,250 140,250 140,250 140,250 140,250 140,250 0.0 0.0   Shareholders equity total   141,795 141,715 141,719 141,683 142,082 144,092 2,092 2,092   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   141,822 141,725 141,757 141,697 142,342 144,992 2,092 2,092   Net Debt   -116 -5.2 -140 -39.0 -70.7 -272 -2,092 -2,092     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   4.9 -148 -35.2 -76.5 456 2,411 0.0 0.0   Gross profit growth   0.0% 0.0% 76.2% -117.5% 0.0% 428.3% -100.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   141,822 141,725 141,757 141,697 142,342 144,992 2,092 2,092   Balance sheet change%   0.0% -0.1% 0.0% -0.0% 0.5% 1.9% -98.6% 0.0%   Added value   4.9 -147.7 -35.2 -76.5 456.4 2,411.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 -140,250 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 -1.0 -2.0 -3.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   0.0% -0.1% 0.0% -0.0% 0.4% 1.8% 0.0% 0.0%   ROI %   0.0% -0.1% 0.0% -0.0% 0.4% 1.8% 0.0% 0.0%   ROE %   0.0% -0.1% 0.0% -0.0% 0.3% 1.4% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   100.0% 100.0% 100.0% 100.0% 99.8% 99.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -2,344.6% 3.5% 397.0% 51.0% -15.5% -11.3% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   59.5 147.5 39.7 103.4 8.1 5.3 0.0 0.0   Current Ratio   59.5 147.5 39.7 103.4 8.1 5.3 0.0 0.0   Cash and cash equivalent   115.7 5.2 139.6 39.0 70.7 271.9 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,545.8 1,465.0 1,468.9 1,433.7 1,832.4 3,842.5 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0